期刊文献+

雷公藤治疗乳腺癌主要活性成分筛选及分子机制探讨 被引量:4

Mechanism and main active ingredients of Radix Et Rhizoma Tripterygii Wilfordii for breast cancer
下载PDF
导出
摘要 目的基于网络药理学筛选雷公藤治疗乳腺癌主要活性成分并初步探讨分子机制。方法利用TCMSP平台获取雷公藤活性成分及作用靶点信息,检索GeneCard数据库筛选雷公藤治疗乳腺癌潜在靶标,将两者进行匹配获得雷公藤治疗乳腺癌核心成分及靶点基因。应用Cytoscape3.6.0、AutoDock Vina等软件,构建活性成分-靶点网络图,进行靶点基因富集分析,完成核心靶标与成分的分子对接。利用CCK8及qPCR等方法验证核心单体成分对乳腺癌细胞及治疗靶点的作用。结果筛选获得雷公藤治疗乳腺癌有效成分7种,核心治疗靶点25个。其中最优成分为雷公藤红素,其对乳腺癌细胞具有明显抑制作用且显著降低核心治疗靶点的mRNA表达。结论雷公藤通过多靶点发挥治疗乳腺癌作用,其中雷公藤红素是其核心药用成分。 Aim To explore the main active ingredients of Tripterygium wilfordii and the mechanism in treat-ment of breast cancer based on network pharmacology.Methods The active components and targets of Tripterygii Wilfordii were searched by TCMSP.GeneCard database was used to screen the potential targets of Tripterygii Wilfordii in treatment of breast cancer.The two were matched to obtain the core components and targets of Tripterygii Wilfordii.Cytoscape3.6.0 and AutoDock Vina were used to draw the drug-target network diagram,and GO enrichment analysis,KEGG pathway enrichment analysis,and molecular docking between the core target and the components were carried out.CCK8 and qPCR were used to verify the effect of optimal core component tripterine on breast cancer cells.Results Seven kinds of active anti-breast cancer components and twenty-five core therapeutic targets of Tripterygii Wilfordii were obtained.Tripterine,which significantly inhibited the growth of breast cancer cells,was the most valuable component of Tripterygii Wilfordii for breast cancer.QPCR results showed that tripterine decreased the expression of core therapeutic targets.Conclusions The effectiveness of Tripterygii Wilfordii has multiple pathways,and tripterine may play an important role in treatment of breast cancer.
作者 陈苹苹 潘永梅 李梦 崔春雪 刘彦双 王丽梅 刘菲 CHEN Ping-ping;PAN Yong-mei;LI Meng;CUI Chun-xue;LIU Yan-shuang;WANG Li-mei;LIU Fei(School of Basic Medical Sciences Hebei University of Chinese Medicine,Shijiazhuang 050200,China;Hebei Key Laboratory of Traditional Chinese Medicine Health Care,Shijiazhuang 050200,China;China College of Imtegrative Medicine,Hebei University of Chinese Medicine,Shijiazhuang 050200,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2022年第10期1565-1572,共8页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 82003990) 河北省自然科学基金(No H2020423252) 河北省中医药管理局课题(No 2020144)。
关键词 雷公藤 乳腺癌 网络药理学 药物靶点 分子对接 雷公藤红素 Tripterygii Wilfordii breast cancer network pharmacology drug target molecular docking tripterine
  • 相关文献

参考文献7

二级参考文献53

  • 1WHO. Globocan 2008 : Estimated cancer as global health concern [J].Cancer incidence, mortality prevalence ald disability-adjus- ted life years (DALYs) worldwise in 2008,2nd January 2013 [OL]. http://globocan.iarc.r/(22 February 2013, date last ac- cessed).
  • 2Ossovskaya V, Wang Y, Budoff A, et al. Exploring molecular pathways of triple-negative breast caneer[J]. Genes Cancer, 2011, 2(9): 870-879.
  • 3Baner KR, Brown M, Cress RD, et al. Descoiptive analysis of estrogen receptor (ER) - negative, progesterone receptor (PR) - negative, and HER2 - negative phenotype a population- based study from the California cancer registry[J]. Cancer, 2007, 109 (9) : 1721-1728.
  • 4Tischkowitz M, Brunet JS, B6gin LR, et al. Use of immunohis-tochemical markers can refine prognosis in triple negative breast caneer[J]. BMC Cancer, 2007, 7: 134.
  • 5AJCC癌症分期手册[M].严正,译.广州:中山大学肿瘤防治中心,2010.
  • 6周际昌.实用肿瘤内科治疗学[M].北京:北京科学技术出版社,2012:32.
  • 7马文碉.卡铂联合紫杉醇治疗局部晚期三阴性乳腺癌的Ⅱ期临床研究[D].北京:北京协和医学院,2011.
  • 8Liu Q. Triptolide and its expanding multiple pharmacological {unetions[J]. Int Immunopharmacol, 2011, 11(3): 377-383.
  • 9Wu MB, Wu YL, Zhou J, et al. Structural characteristation of a water-soluble polysaecharide with high branches from the leaves of Taxus chinensis var mairei[J]. Food Chem, 2009, 113:1020-1024.
  • 10张建国,苏永华.华蟾酥毒基药理作用及剂型研究进展[J].浙江中医药大学学报,2009,33(4):608-610. 被引量:8

共引文献162

同被引文献33

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部